Sangamo Therapeutics and Astellas Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases Business Wire Nawigacja wpisu Vertex touts pain drug results, but medicine does not outperform placebo in sciatica study – STAT Cancer Cachexia and the Brain Stem – nejm.org
